- Home
- ZUMZ vs LXEO Comparison
ZUMZ vs LXEO Comparison
Compare ZUMZ & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZUMZ | LXEO |
|---|---|---|
| Founded | 1978 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.7M | 486.1M |
| IPO Year | 2005 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ZUMZ | LXEO |
|---|---|---|
| Price | $22.28 | $5.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $18.00 | ★ $18.60 |
| AVG Volume (30 Days) | 175.5K | ★ 700.1K |
| Earning Date | 03-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | 75.08 |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $929,057,000.00 | $654,000.00 |
| Revenue This Year | $3.71 | N/A |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | $28.03 | ★ N/A |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $11.31 | $1.45 |
| 52 Week High | $31.70 | $10.99 |
Technical Indicators
Market Signals| Indicator | ZUMZ | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 34.96 |
| Support Level | $19.85 | $4.67 |
| Resistance Level | $22.96 | $7.77 |
| Average True Range (ATR) | 1.21 | 0.47 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 53.60 | 18.68 |
Price Performance
Historical ComparisonAbout ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.